HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News:
Karo Bio AB: (STO:KARO)
THE FULL YEAR AND THE FOURTH QUARTER
· Net sales increased to MSEK 69.1 (30.1), whereof the fourth quarter MSEK 57.4 (8.1)
Karo Bio AB: (STO:KARO)
THE FULL YEAR AND THE FOURTH QUARTER
· Net sales increased to MSEK 69.1 (30.1), whereof the fourth quarter MSEK 57.4 (8.1)